
    
      Viral reactivation and infection is a major cause of morbidity in immunocompromised patients
      (including HSCT recipients). In this study we will draw blood from unrelated (third party)
      donors and use the blood to generate viral specific T-cells (VSTs) with specificity for
      Epstein-Barr virus (EBV), cytomegalovirus (CMV), adenovirus (ADV), BK virus (BKV), and JC
      Virus. The VSTs will be infused into immunocompromised children with specific viral
      infections (EBV, CMV, ADV, BKV , or JC virus). Cells will be selected for infusion based on
      the recipient's HLA type and the viral specificity of the cells.
    
  